Blocking RhoA enzyme increases survival in SMA mouse model
Links shared publicly online about this topic.
- 1,310total visits
Blocking RhoA enzyme increases survival in SMA mouse model
Scientists from the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa have identified a promising new approach for developing drugs to treat Spinal muscular atrophy (SMA), the leading inherited cause of death in infants and toddlers. Dr. Rashmi Kothary and his doctoral student Melissa Bowerman have found that an enzyme called RhoA is overly active in a mouse model of the disease and blocking this enzyme can greatly increase survival. The study is published in Human Molecular
View full resource at buzzup.com
Tags: Genetic, Disease and Condition, Drug, Hospital, Children's Health, Scientist, Hospitals
Most Recently Shared on March 16, 2010 at 6:18 pm By:
Genetics News: Blocking RhoA enzyme increases survival in SMA mouse model: Scientists from the Ottawa Hospital R... http://buzzup.com/qkcz
Advertisement
